EIDD-1931
Product Specifications
CAS Number
3258-02-4
Target
SARS-CoV, HCV Protease, Virus Protease, Topoisomerase
Related Pathways
DNA Damage/DNA Repair, Microbiology/Virology, Proteases/Proteasome
Purity
0.9973
Bioactivity
EIDD-1931 (Beta-d-N4-hydroxycytidine) is a ribonucleoside analog with antiviral activity that inhibits the replication of severe acute respiratory syndrome coronavirus [SARS-CoV] in Vero 76 cells, Middle East respiratory syndrome coronavirus [MERS-CoV] in Calu-3 2B4 cells, and SARS-CoV-2 in Vero cells (IC50s = 0.1, 0.15, and 0.3 μM, respectively) .
Smiles
OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n1cc\c(=N/O)[nH]c1=O
Molecular Formula
C9H13N3O6
Molecular Weight
259.22
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS1313903-01 0.5 mg (E-Coli)
Recombinant Mouse Glucoside xylosyltransferase 2 (Gxylt2), partial
Sign In for Pricing
View Details MBS1313903-02 0.05 mg (Baculovirus)
Recombinant Mouse Glucoside xylosyltransferase 2 (Gxylt2), partial
Sign In for Pricing
View Details MBS1313903-03 0.5 mg (Yeast)
Recombinant Mouse Glucoside xylosyltransferase 2 (Gxylt2), partial
Sign In for Pricing
View Details 
MBS1313903-04 0.05 mg (Mammalian-Cell)
Recombinant Mouse Glucoside xylosyltransferase 2 (Gxylt2), partial
Sign In for Pricing
View Details MBS1313903-05 1 mg (E-Coli)
Recombinant Mouse Glucoside xylosyltransferase 2 (Gxylt2), partial
Sign In for Pricing
View Details